Weekly Docetaxel/Paclitaxel in Pretreated Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Weekly Docetaxel/Paclitaxel in Pretreated Metastatic Breast Cancer

Published:2002-12 Issue:5 Volume:3 Page:346-352
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Gennari Alessandra,Guarneri Valentina,Landucci Elisabetta,Orlandini Cinzia,Rondini Marianna,Salvadori Barbara,Ricci Sergio,Conte Pier Franco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dosefinding and sequence-finding study;Gianni;J Clin Oncol,1995

2. Combined doxorubicin and paclitaxel in advanced breast cancer: effective and cardiotoxic;Gehl;Ann Oncol,1996

3. Three-year follow up in women with metastatic breast cancer after bolus doxorubicin and paclitaxel infused over 3 hours (AT);Valagussa;Proc Am Soc Clin Oncol,1998

4. Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer;Conte;J Clin Oncol,1997

5. Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer;Nabholtz;Semin Oncol,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy;Bioorganic & Medicinal Chemistry Letters;2019-06

2. Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy;Journal of Medicinal Chemistry;2016-03-22

3. Weekly Administration of Docetaxel and Paclitaxel in Metastatic or Advanced Breast Cancer;The Oncologist;2005-10-01

4. Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer;Current Oncology Reports;2005-02

5. Taxanes in elderly breast cancer patients;Cancer Treatment Reviews;2004-06